2024 Europe Drugs of Abuse Testing Market for 12 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

August 2024 | - | ID: 231E244FC70CEN
Venture Planning Group

Abstracts

This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.Contains 300 pages and 48 tables/p>

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Drugs of Abuse

1. OVERVIEW

2. TEST METHODOLOGIES

3. AMPHETAMINES

4. BARBITURATES

5. BENZODIAZEPINES

6. CANNABINOIDS/MARIJUANA

7. COCAINE

8. LYSERGIC ACID DIETHYLAMIDE (LSD)

9. METHADONE

10. METHAQUALONE

11. OPIATES

12. PHENCYCLIDINE

13. TRICYCLIC ANTIDEPRESSANTS

B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alfa Wassermann, AMS,
Awareness Technologies, Beckman Coulter, Binding Site,
bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics,
Polymedco, Randox, Roche, Siemens, Tosoh, Vital
Diagnostics and other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
Table of Contents (Continued)
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

3. TANDEM MASS SPEC

4. IT AND AUTOMATION

5. DRY CHEMISTRY

6. BIOSENSORS

France: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Spain: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS